By Helen Greta, Director, Project Management at Cenduit IRT, an IQVIA business
In recent years, clinical trials have undergone a widespread adoption of mobile devices, sensors, and wearables through patient-centric Decentralized Trials (DCT). Not only has the shift in trial design improved patient enrollment and participation rates, but the new technologies have also provided researchers with a large volume of data and insights. As a result, the FDA has issued guidelines for the implementation of Digital Health Technologies (DHT).
While this has been very beneficial for the life sciences industry, it has also added complexity to medical studies. According to reports, the increased use of technology and data collection has added a burden to site staff, who must collate, enter, and reconcile data across multiple systems.
The solution is to integrate technology and process through orchestrated solution build, delivery, and management, which allows for rapid study start-up, flexible mid-study changes, and unified study management. Learn more about IQVIA's Orchestrated Clinical Trials (OCT) tech suite, an example of this approach, that utilizes Integrated Response Technologies (IRT) for Randomization and Trial Supply Management (RTSM) and electronic Clinical Outcomes Assessments (eCOA) to streamline and simplify clinical research processes.